Heterocyclic Compounds as Bcr-Abl Tyrosine Kinase Inhibitors Against Chronic Myeloid Leukemia

S Gado, MAK Hassan, MM Kisla… - Medicinal …, 2024 - benthamdirect.com
Despite significant progress in oncology therapeutics, cancer remains a leading cause of
mortality worldwide. Chronic myeloid leukemia, which accounts for 15% of all adult leukemia …